The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 395 | 13,263 | SH | SOLE | 13,263 | 0 | 0 | ||
ADIENT PLC | ORD SHS | G0084W101 | 344 | 4,737 | SH | SOLE | 4,737 | 0 | 0 | ||
AGILE THERAPEUTICS INC | COM | 00847L100 | 5,204 | 1,623,567 | SH | SOLE | 1,623,567 | 0 | 0 | ||
BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 1,491 | 8,945 | SH | SOLE | 8,945 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 162 | 20,802 | SH | SOLE | 20,802 | 0 | 0 | ||
CM FIN INC | COM | 12574Q103 | 540 | 53,204 | SH | SOLE | 53,204 | 0 | 0 | ||
GARRISON CAP INC | COM | 366554103 | 646 | 66,073 | SH | SOLE | 66,073 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 289 | 1,992 | SH | SOLE | 1,992 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 25,626 | 5,394,994 | SH | SOLE | 5,394,994 | 0 | 0 | ||
TEAM HEALTH HOLDINGS INC | COM | 87817A107 | 336 | 7,713 | SH | SOLE | 7,713 | 0 | 0 |